This inventor holds 2 USPTO granted patents. Top assignees: Cubist Pharmaceuticals, Incorporated, Xenova Limited. Active years: 2003-2004.
Company Filing History:
Years Active: 2003-2004
Title: David Andrew Kau: Innovator in Cytokine Production Inhibition
Introduction
David Andrew Kau is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of cytokine production inhibitors. With a total of 2 patents to his name, Kau's work has implications for treating immunoinflammatory and cancerous conditions.
Latest Patents
Kau's latest patents include innovative compounds aimed at inhibiting cytokine production and tyrosine kinase activity. One of his patents describes a compound of formula (I), which includes various structural components that contribute to its activity as a cytokine production inhibitor. The patent outlines processes for producing these compounds from fungal strains and synthetic analogues, showcasing their potential therapeutic applications.
Career Highlights
Throughout his career, Kau has worked with prominent companies in the pharmaceutical industry, including Cubist Pharmaceuticals and Xenova Limited. His experience in these organizations has allowed him to refine his expertise in drug development and biotechnology.
Collaborations
Kau has collaborated with notable professionals in his field, including Stephen Keith Wrigley and Sangeeta Bahl. These partnerships have likely contributed to the advancement of his research and innovations.
Conclusion
David Andrew Kau's contributions to biotechnology, particularly in cytokine production inhibition, highlight his role as an influential inventor. His patents and career achievements reflect a commitment to advancing medical science and improving treatment options for various conditions.